Van Os To Oversee Product & Technology Development For Magstim TMS, Electrical Geodesics (EGI) EEG, Technomed Neurophysiology and Neurosign Intraoperative Nerve Monitoring Brands
Magstim Acquires Electrical Geodesics, Inc. (EGI) Product Portfolio High-density EEG complements Magstim’s Transcranial Magnetic Stimulation Technology Driving Innovation MINNEAPOLIS, Minn. & Carmarthenshire, UK — (July 2, 2020) – Magstim, the
Magstim Academy Lecture Series – Rhythm and Acceleration – recent advances in TMS treatment for mood disorders. Mark George, MD, Nolan Williams, MD and Martijn Arns, PhD will present on their recently published and on-going TMS studies.
Magstim Academy Lecture Series – this live series will begin on May 12th and cover cutting-edge magnetic stimulation research.
My team would like to thank all the TMS clinicians and treaters who continue to provide life-changing TMS treatments safely to their patients during the COVID-19 crisis. We recognize your
Magstim® TMS has launched the very first Transcranial Magnetic Stimulation navigation system specifically developed for the clinical market.
Magstim has received FDA clearance to include intermittent Theta Burst Stimulation (iTBS) as a treatment for Major Depressive Disorder with its Horizon® TMS Therapy systems.
Take a look inside Magstim. At Magstim, we believe in developing cost-effective, innovative TMS solutions, enabling ground breaking neuroscience research & TMS Therapy. Dr. M. Polson gives us a look
How we treat depression in the future may be set to change as the NHS begins an unprecedented two year study using transcranial magnetic stimulation (TMS).
Magstim Group, Inc., the pioneer in trans-cranial magnetic stimulation and intraoperative nerve monitoring, today announced that it has appointed Lothar Krinke, Ph.D., as Chief Executive Officer effective immediately. Dr. Krinke will serve on the Board of Directors of Magstim. He will be responsible for Magstim and Technomed.
